1.
Zh Nevrol Psikhiatr Im S S Korsakova
; Suppl 15: 13-27, 2005.
Artigo
em Russo
| MEDLINE
| ID: mdl-16447549
RESUMO
The benefits and limitations of intravenous thrombolytic therapy using recombinant tissue plasminogen activator (alteplase) are discussed. Pathophysiological background of thrombolysis, its history and ways of clinical usage, the major clinical trials, assessing safety and efficacy of the method, and practical recommendations, are presented.
Assuntos
Isquemia Encefálica/tratamento farmacológico , Fibrinolíticos/administração & dosagem , Terapia Trombolítica/métodos , Fibrinolíticos/uso terapêutico , Humanos , Injeções Intravenosas , Ativador de Plasminogênio Tecidual/administração & dosagem , Ativador de Plasminogênio Tecidual/uso terapêutico , Resultado do Tratamento
2.
Ukr Biokhim Zh (1978)
; 69(3): 109-11, 1997.
Artigo
em Russo
| MEDLINE
| ID: mdl-9505370
RESUMO
The spectra of 31P-NMR erythrocytes in patients with initial symptoms of cerebral circulation insufficiency compared to blood-donors were analysed. The expansion of 31P-NMR ATP and 2,3-DPG signals is observed in pathology. On these grounds the authors have come to a conclusion that the population of erythrocytes is more heterogeneous as to oxygen saturation than in normal state.